Glenn Greenwald, Best-Selling Author & Journalist | May 30, 2019
Lately the question of privacy has taken on a whole new significance: namely, the economic imperative for data managers and companies to balance the commercial benefits of exploiting personal data with the commercial loss of developing a reputation as an unreliable guardian of users' privacy. Watch the highlights below, you can request access to the full video.
The right to privacy is typically debated as a political and ethical question. And it most certainly is that: the extent to which citizens are willing to have powerful governmental and corporate entities know intimate details of their lives, choices and actions in exchange for promised benefits plays a crucial role in how various components of our society is shaped. But lately the question of privacy has taken on a whole new significance: namely, the economic imperative for data managers and companies to balance the commercial benefits of exploiting personal data with the commercial lost of developing a reputation as an unreliable guardian of users' privacy.
This session was held at the RavenPack Research Symposium held in London on May 23, 2019 .
Register for our next event >
Please use your business email. If you don't have one, please email us at info@ravenpack.com.
We will process your personal data with the purpose of managing your personal account on RavenPack and offering our services. You can exercise your rights of access, rectification, erasure, restriction of processing, data portability and objection by emailing us at privacy@ravenpack.com. For more information, you can check out our Privacy Policy.
Your request has been recorded and a team member will be in touch soon.
We consider incorporating sentiment signals from news, earnings call transcripts, and insider transactions to boost the risk-adjusted returns, and revive factor performance.
We find stronger, more predictable market reactions when the words of company executives agree with their actions.
We have gathered 12 insights from 2021 research that can be leveraged in 2022.